Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMORN60)

Drug Name
CBL0137 Drug Info
Indication
Disease Entry ICD 11 Status REF
Advanced solid tumour 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
44519124
ChEBI ID
CHEBI:138650
CAS Number
CAS 1197996-80-7
TTD Drug ID
DMORN60

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Facilitates chromatin transcription complex (FACT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CBL0102 DMKCJ75 Hepatocellular carcinoma 2C12.02 Phase 1/2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Facilitates chromatin transcription complex (FACT) TTETDKQ SSRP1_HUMAN Modulator [2]

References

1 ClinicalTrials.gov (NCT01905228) A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm or Refractory Lymphomas. U.S. National Institutes of Health.
2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3 Company report (Incuron)